Dr. Silverstein on Oncoplasty Versus Mastectomy for Patients With Breast Cancer

Melvin J. Silverstein, MD, FACS
Published: Friday, Jul 31, 2015



Melvin J. Silverstein, MD, FACS, medical director, Hoag Breast Center, Gross Family Foundation Endowed Chair in Oncoplastic Breast Surgery, Hoag Memorial Hospital Presbyterian, compares oncoplastic surgery with mastectomy for patients with breast cancer.

Mastectomy rates have risen in the United States over the last decade, Silverstein explains. Moreover, double mastectomy rates have increased by 10% during this time.

Patients with breast cancer are encouraged to meet with an oncoplastic surgeon for a second opinion after being recommended to have a mastectomy, Silverstein adds. Surgeons conduct mammographies, ultrasounds, magnetic resonance imaging scans, and evaluations by specialists in plastic surgery, medical oncology, pathology, and surgical oncology. The multidisciplinary approach is used to determine if this breast-conserving surgery is the best option for a patient.


Melvin J. Silverstein, MD, FACS, medical director, Hoag Breast Center, Gross Family Foundation Endowed Chair in Oncoplastic Breast Surgery, Hoag Memorial Hospital Presbyterian, compares oncoplastic surgery with mastectomy for patients with breast cancer.

Mastectomy rates have risen in the United States over the last decade, Silverstein explains. Moreover, double mastectomy rates have increased by 10% during this time.

Patients with breast cancer are encouraged to meet with an oncoplastic surgeon for a second opinion after being recommended to have a mastectomy, Silverstein adds. Surgeons conduct mammographies, ultrasounds, magnetic resonance imaging scans, and evaluations by specialists in plastic surgery, medical oncology, pathology, and surgical oncology. The multidisciplinary approach is used to determine if this breast-conserving surgery is the best option for a patient.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x